Search published articles


Showing 2 results for Enterotoxin

T Dadgar, E Ghaemi, N Bahador, A Imani Fooladi, F Kamareie,
Volume 7, Issue 5 (2-2014)
Abstract

Abstract Background and Objective: The main cause of spreading staphylococcal infections among patients is the healthy carriers working in hospitals. With the secretion of different sorts of toxins such as entrotoxin, this bacteria can provide the conditions for attacking on the host. The main objective of this study is identification of the characteristics and differences in the Staphylococcus aureus isolated from healthy carriers and from the patients on the basis of enterotoxin genes (sea-see). Material and Methods: One hundred and twenty of the patients and 80 of healthy carriers worked in health centers of Gorgan, north of Iran, were investigated for S. aureus isolate. The isolates were evaluated by PCR for Enterotoxin Genes A-E (SEA to SEE). Results: Enterotoxin genes (SEA to SEE) was found in 87.5% of the total isolates and the most frequent one was enterotoxin gene sea (N= 124). The prevalence of these isolates in healthy carriers was significantly higher than those of the patients. Conclusion: Based on the results, the high percentage of S. aureus isolated from clinical samples contains enterotoxin genes. Therefore, Human as the source and carrier of S. aureus is paramount importance, which is due to significant relationship between being toxigenic strains and the source of isolation. Key words: Staphylococcus Aureus Enterotoxin Patient Carrier
Fatemeh Maghsood Ahmadi , Arash Mahboubi , Farzaneh Hosseini , Davoud Esmaeili , Bahareh Hajikhani ,
Volume 19, Issue 5 (9-2025)
Abstract

Background: Lactic acid bacteria (LAB) are promising platforms for mucosal vaccine development. Staphylococcus aureus enterotoxin B (SEB), a potent superantigen, is associated with food poisoning and toxic shock syndrome. Similarly, cholera toxin is the primary to widespread virulence factor in Vibrio cholerae infections, with its B subunit (CTB) serving as a well-established immune adjuvant that enhances antigen-specific responses in recombinant vaccines. This study aimed to engineer recombinant Lactobacillus plantarum as a dual-purpose vaccine candidate targeting V. cholerae and S. aureus by expressing CTB and SEB antigens.
Methods: A modified gene sequence encoding SEB (Lacking superantigenic activity) and CTB was successfully designed, synthesized, and cloned for secretory expression in L. plantarum. The resulting recombinant protein, tagged with His, was purified using Ni-NTA agarose ion-exchange chromatography and confirmed with Western blot analysis.
Results: Enzyme digestion and PCR analysis confirmed successful cloning of the SEB-CTB fusion gene into the pBlueScript II SK (+) and pNZ7021 expression vectors, as evidenced by the expected band on agarose gel. SDS-PAGE revealed a ~49 kDa protein band, indicating expression of the recombinant rSEB-CTB protein, which was further validated by Western blot using an anti-His tag antibody.
Conclusion: The construct LP-pNZ7021–SP-seb-ctxB may be a promising candidate for recombinant vaccine development targeting V. cholerae (Cholera toxin-producing) and S. aureus (SEB-producing), providing dual protection against both pathogens.

 


Page 1 from 1